7.78
+0.34(+4.57%)
Currency In USD
| Previous Close | 7.44 |
| Open | 6.3 |
| Day High | 8.78 |
| Day Low | 6.25 |
| 52-Week High | 903.86 |
| 52-Week Low | 4.29 |
| Volume | 416,459 |
| Average Volume | 1.18M |
| Market Cap | 3.3M |
| PE | 0.07 |
| EPS | 116.66 |
| Moving Average 50 Days | 5.98 |
| Moving Average 200 Days | 16.9 |
| Change | 0.34 |
Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire Inc.
Sep 04, 2025 1:54 PM GMT
Northstrive Biosciences and Yuva Biosciences previously announced the AI Development Program, a collaboration leveraging MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel ph
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
GlobeNewswire Inc.
Aug 28, 2025 2:30 PM GMT
NEWPORT BEACH, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-3.5 reverse stock split (the “Split”) of its issued and outstanding and authorized comm
PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules
GlobeNewswire Inc.
Aug 22, 2025 5:48 PM GMT
NEWPORT BEACH, Calif., Aug. 22, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (Nasdaq: ELAB) a diversified holding company today announced it has entered into a warrant inducement agreement with existing institutional invest